Annals of Allergy, Asthma & Immunology · Nov 2026

LIPOPOLYSACCHARIDE-BINDING PROTEIN AND HSCRP ALGORITHM FOR CARDIOVASCULAR RISK STRATIFICATION IN TYPE 1 DIABETES PATIENTS

By Useinova R, Beloglazov V, Yatskov I et al.

Introduction Standard risk scores (SCORE2) are not validated for young patients with type 1 diabetes (T1D). Biomarkers reflecting endotoxin-mediated inflammation may improve early risk detection. Methods 78 patients with T1D (45 without hypertension, 33 with hypertension) were evaluated. Plasma lipopolysaccharide-binding protein (LBP), high-sensitivity C-reactive protein (hsCRP), and HDL cholesterol were measured. ROC analysis was performed for left ventricular mass index (LVMI). An integrated step-wise algorithm combining biomarkers, clinical “red flags” (diabetes duration >10 years, poor glycemic control, albuminuria), ambulatory blood pressure monitoring and echocardiography was developed. Results Cut-off values predicting myocardial remodeling were: LBP >8.02 µg/mL (AUC 0.778, p=0.001, sensitivity 88.9%, specificity 66.7%); hsCRP >1.62 mg/L (AUC 0.767, p=0.001, sensitivity 80.0%, specificity 91.7%); HDL ≤1.34 mmol/L (AUC 0.736, p=0.001, sensitivity 76.9%, specificity 77.3%). The algorithm assigns patients to three risk categories (relatively low, intermediate/high, maximal individual) and guides targeted screening. Conclusion Integrating inflammatory markers LBP, hsCRP and HDL into a step-wise algorithm enables early, pathogenic based cardiovascular risk stratification in T1D patients, including those in whom traditional scores are inapplicable.

doi.org/10.1016/j.anai.2026.09.204Biomarkers

AgingResearch.News